{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T20:59:47Z","timestamp":1794344387083,"version":"4.9.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease that has undergone extensive phenotypic expansion since being first described in patients with fevers, recurrent strokes, livedo racemosa, and polyarteritis nodosa in 2014. It is now recognized that patients may develop multisystem disease that spans multiple medical subspecialties. Here, we describe the findings from a large single center longitudinal cohort of 60 patients, the broad phenotypic presentation, as well as highlight the cohort\u2019s experience with hematopoietic cell transplantation and COVID-19. Disease manifestations could be separated into three major phenotypes: inflammatory\/vascular, immune dysregulatory, and hematologic, however, most patients presented with significant overlap between these three phenotype groups. The cardinal features of the inflammatory\/vascular group included cutaneous manifestations and stroke. Evidence of immune dysregulation was commonly observed, including hypogammaglobulinemia, absent to low class-switched memory B cells, and inadequate response to vaccination. Despite these findings, infectious complications were exceedingly rare in this cohort. Hematologic findings including pure red cell aplasia (PRCA), immune-mediated neutropenia, and pancytopenia were observed in half of patients. We significantly extended our experience using anti-TNF agents, with no strokes observed in 2026 patient months on TNF inhibitors. Meanwhile, hematologic and immune features had a more varied response to anti-TNF therapy. Six patients received a total of 10 allogeneic hematopoietic cell transplant (HCT) procedures, with secondary graft failure necessitating repeat HCTs in three patients, as well as unplanned donor cell infusions to avoid graft rejection. All transplanted patients had been on anti-TNF agents prior to HCT and received varying degrees of reduced-intensity or non-myeloablative conditioning. All transplanted patients are still alive and have discontinued anti-TNF therapy. The long-term follow up afforded by this large single-center study underscores the clinical heterogeneity of DADA2 and the potential for phenotypes to evolve in any individual patient.<\/jats:p>","DOI":"10.3389\/fimmu.2021.811473","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T23:53:18Z","timestamp":1641772398000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort"],"prefix":"10.3389","volume":"12","author":[{"given":"Karyl S.","family":"Barron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Aksentijevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie T.","family":"Deuitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Videgar-Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Soldatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Bergerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Cudrici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Nehrebecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kanakry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimana","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawwa","family":"Alao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Kapuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Ben-Yakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique C.","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Londa","family":"Hathaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Brofferio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"McRae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Sampaio","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Schnappauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Cowen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Ombrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-Onset Stroke and Vasculopathy Associated With Mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S0091-6749(21)01693-6","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"TNF-Inhibition in Vasculitis Management in Adenosine Deaminase 2 Deficiency (DADA2)","author":"Deuitch","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1182\/blood.2018892752","article-title":"Deficiency of Adenosine Deaminase 2 Triggers Adenosine-Mediated NETosis and TNF Production in Patients With DADA2","volume":"134","author":"Carmona-Rivera","year":"2019","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001251","article-title":"NETing the Mechanism of Inflammation in DADA2","volume":"134","author":"Lee","year":"2019","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1546-0096-12-44","article-title":"Mutations in CECR1 Associated With a Neutrophil Signature in Peripheral Blood","volume":"12","author":"Belot","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"eaba3688","DOI":"10.1126\/sciadv.aba3688","article-title":"Cellular of Extracellular Purine Nucleosides Triggers an Innate IFN-Beta Response","volume":"6","author":"Dhanwani","year":"2020","journal-title":"Sci Adv"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.01.018","article-title":"Detailed Analysis of Japanese Patients With Adenosine Deaminase 2 Deficiency Reveals Characteristic Elevation of Type II Interferon Signature and STAT1 Hyperactivation","volume":"148","author":"Nihira","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaci.2016.03.016","article-title":"Adenosine Deaminase Type 2 Deficiency Masquerading as GATA2 Deficiency: Successful Hematopoietic Stem Cell Transplantation","volume":"138","author":"Hsu","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00817-3","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): Hidden Variants, Reduced Penetrance, and Unusual Inheritance","volume":"40","author":"Schnappauf","year":"2020","journal-title":"J Clin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","article-title":"Genotype and Functional Correlates of Disease Phenotype in Deficiency of Adenosine Deaminase 2 (DADA2)","volume":"145","author":"Lee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"S0091-6749(21)00733-8","DOI":"10.1016\/j.jaci.2021.04.034","article-title":"Comprehensive Analysis of ADA2 Genetic Variants and Estimation of Carrier Frequency Driven by a Function-Based Approach","author":"Jee","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0565-0","article-title":"Warts and DADA2: A Mere Coincidence","volume":"38","author":"Arts","year":"2018","journal-title":"J Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jaci.2018.05.038","article-title":"Disrupted N-Linked Glycosylation as a Disease Mechanism in Deficiency of ADA2","volume":"142","author":"Lee","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7019","article-title":"Widening the Neuroimaging Features of Adenosine Deaminase 2 Deficiency","volume":"42","author":"Geraldo","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00734-0","article-title":"ADA2 Deficiency: Case Series of Five Patients With Varying Phenotypes","volume":"40","author":"Tanatar","year":"2020","journal-title":"J Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1517\/14712598.2012.646986","article-title":"Anti-TNF Drugs in Patients With Hepatitis B or C Virus Infection: Safety and Clinical Management","volume":"12","author":"Vigano","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-007-9053-z","article-title":"The Treatment With Antibody of TNF-Alpha Reduces the Inflammation, Necrosis and Fibrosis in the Non-Alcoholic Steatohepatitis Induced by Methionine- and Choline-Deficient Diet","volume":"31","author":"Koca","year":"2008","journal-title":"Inflammation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.06.058","article-title":"Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency","volume":"177","author":"Ben-Ami","year":"2016","journal-title":"J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000805","article-title":"Refractory Pure Red Cell Aplasia Manifesting as Deficiency of Adenosine Deaminase 2","volume":"39","author":"Hashem","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment Strategies for Deficiency of Adenosine Deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa837","article-title":"Anti-Tumour Necrosis Factor Treatment for the Prevention of Ischaemic Events in Patients With Deficiency of Adenosine Deaminase 2 (DADA2)","volume":"60","author":"Cooray","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/art.39699","article-title":"Deficiency of Adenosine Deaminase Type 2: A Description of Phenotype and Genotype in Fifteen Cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B25","first-page":"1993","article-title":"Adenosine Deaminase 2 Deficiency","volume-title":"GeneReviews","author":"Aksentijevich","year":"2019"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/art.40147","article-title":"Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood","volume":"69","author":"Schepp","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0245-x","article-title":"Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency","volume":"36","author":"Schepp","year":"2016","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048549","article-title":"Dysregulation in B-Cell Responses and T Follicular Helper Cell Function in ADA2 Deficiency Patients","author":"Schena","year":"2020","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01098-0","article-title":"Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients","volume":"41","author":"Hashem","year":"2021","journal-title":"J Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrrheum.2014.158","article-title":"New Players Driving Inflammation in Monogenic Autoinflammatory Diseases","volume":"11","author":"Martinon","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210802","article-title":"ADA2 Deficiency (DADA2) as an Unrecognised Cause of Early Onset Polyarteritis Nodosa and Stroke: A Multicentre National Study","volume":"76","author":"Caorsi","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.04.008","article-title":"Outcomes of Related and Unrelated Donor Searches Among Patients With Primary Immunodeficiency Diseases Referred for Allogeneic Hematopoietic Cell Transplantation","volume":"25","author":"Acevedo","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003811","article-title":"Lentiviral Correction of Enzymatic Activity Restrains Macrophage Inflammation in Adenosine Deaminase 2 Deficiency","volume":"5","author":"Zoccolillo","year":"2021","journal-title":"Blood Adv"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/BOR.0000000000000669","article-title":"A Monogenic Autoinflammatory Disease With Fatal Vasculitis: Deficiency of Adenosine Deaminase 2","volume":"32","author":"Sahin","year":"2020","journal-title":"Curr Opin Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.811473\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T08:54:13Z","timestamp":1641977653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.811473\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2021.811473"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.811473","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2021.811473.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2021.811473.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"article-number":"811473"}}